Comparison of Prodromal Symptoms of Patients with Behavioral Variant Frontotemporal Dementia and Alzheimer Disease.


Journal

Dementia and geriatric cognitive disorders
ISSN: 1421-9824
Titre abrégé: Dement Geriatr Cogn Disord
Pays: Switzerland
ID NLM: 9705200

Informations de publication

Date de publication:
2020
Historique:
received: 11 02 2020
accepted: 26 03 2020
pubmed: 3 6 2020
medline: 26 1 2021
entrez: 3 6 2020
Statut: ppublish

Résumé

Behavioral variant frontotemporal dementia (bvFTD) is the most common clinical subtype of frontotemporal lobar degeneration. bvFTD is often characterized by changes in behavior and personality, frequently leading to psychiatric misdiagnoses. On the other hand, substantial clinical overlap with other neurodegenerative diseases, such as Alzheimer disease (AD), further complicates the diagnostics. Our aim was to identify the main differences in early symptoms of bvFTD and AD in the prodromal stages of the diseases. In addition, patients with bvFTD were analyzed separately according to whether they carry the C9orf72repeat expansion or not. Patient records of bvFTD (n = 75) and AD (n = 83) patients were analyzed retrospectively for memory and neuropsychiatric symptoms, sleeping disorders, and somatic complaints before the setting of the accurate diagnosis. A total of 84% of bvFTD patients (n = 63) and 98.8% of AD patients (n = 82) reported subjective memory disturbances in the prodromal phases of the disease. bvFTD patients presented significantly more often with sleeping disorders, headache, inexplicable collapses, transient loss of consciousness, somatization, delusions, and hallucinations, suicidality, changes in oral behaviors, and urinary problems. In addition, poor financial judgement was frequently detected in patients with prodromal bvFTD. Aberrant sensations in the nose and throat without any physical explanation, regarded as somatizations, emerged only in bvFTD patients with the C9orf72 repeat expansion. Subjective reporting of impaired episodic memory is a poor indicator in differentiating bvFTD from AD. Sleeping disturbances, delusions, hallucinations, and unexplained somatic complaints in a patient with cognitive disturbances should prompt the clinicians to consider bvFTD as a possible diagnostic option behind these symptoms. The spectrum of symptoms in the prodromal stages of bvFTD may be more diverse than the latest criteria suggest.

Identifiants

pubmed: 32485711
pii: 000507544
doi: 10.1159/000507544
doi:

Substances chimiques

C9orf72 Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

98-106

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Titta Korhonen (T)

Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland.

Kasper Katisko (K)

Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland.

Antti Cajanus (A)

Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland.

Päivi Hartikainen (P)

Neuro Center, Neurology, Kuopio University Hospital, Kuopio, Finland.

Anne M Koivisto (AM)

Neuro Center, Neurology, Kuopio University Hospital, Kuopio, Finland.

Annakaisa Haapasalo (A)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Anne M Remes (AM)

Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland.
Neuro Center, Neurology, Kuopio University Hospital, Kuopio, Finland.
Research Unit of Clinical Neuroscience, Neurology, University of Oulu, Oulu, Finland.
Medical Research Center, Oulu University Hospital, Oulu, Finland.

Eino Solje (E)

Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland, eino.solje@uef.fi.
Neuro Center, Neurology, Kuopio University Hospital, Kuopio, Finland, eino.solje@uef.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH